IRIS
PUCCINI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.834
NA - Nord America 1.459
SA - Sud America 440
EU - Europa 324
AF - Africa 50
Totale 4.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.386
SG - Singapore 983
CN - Cina 372
BR - Brasile 345
VN - Vietnam 194
IT - Italia 98
HK - Hong Kong 83
FR - Francia 45
IN - India 44
DE - Germania 37
AR - Argentina 30
CA - Canada 30
BD - Bangladesh 27
GB - Regno Unito 27
MX - Messico 24
EC - Ecuador 20
ID - Indonesia 19
AT - Austria 18
TR - Turchia 17
CL - Cile 13
PL - Polonia 13
ES - Italia 12
MA - Marocco 12
CO - Colombia 11
FI - Finlandia 11
IQ - Iraq 11
JP - Giappone 10
NL - Olanda 10
ZA - Sudafrica 10
MY - Malesia 9
RU - Federazione Russa 9
SE - Svezia 9
EG - Egitto 8
SA - Arabia Saudita 8
JM - Giamaica 7
PH - Filippine 7
UY - Uruguay 7
VE - Venezuela 7
DZ - Algeria 5
KZ - Kazakistan 5
LT - Lituania 5
PY - Paraguay 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
KE - Kenya 4
NP - Nepal 4
TN - Tunisia 4
CY - Cipro 3
PK - Pakistan 3
QA - Qatar 3
RS - Serbia 3
UZ - Uzbekistan 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
ZM - Zambia 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 4.105
Salva come PNG Salva come JPEG
Città #
Dallas 506
Singapore 401
Ashburn 207
San Jose 176
Beijing 160
The Dalles 151
Ho Chi Minh City 83
Hong Kong 83
Los Angeles 34
Hanoi 32
São Paulo 29
Santa Clara 27
Milan 23
New York 22
Shanghai 22
Assago 16
Naples 16
Chennai 14
Mexico City 14
Curitiba 13
Orem 13
Buffalo 12
Helsinki 11
Belo Horizonte 10
Guayaquil 10
Montreal 9
Nuremberg 9
Rio de Janeiro 9
Warsaw 9
Haiphong 8
Hải Dương 8
Jakarta 8
London 8
Tongling 8
Ankara 7
Biên Hòa 7
Brasília 7
Dhaka 7
Porto Alegre 7
Quito 7
Rome 7
Tokyo 7
Vienna 7
Baghdad 6
Chicago 6
Montevideo 6
Stockholm 6
Toronto 6
Can Tho 5
Charlotte 5
Denver 5
Goiânia 5
Hillsboro 5
Johannesburg 5
Manaus 5
Paris 5
Reston 5
Ribeirão Preto 5
Atlanta 4
Bogotá 4
Brooklyn 4
Campinas 4
Chengdu 4
Da Nang 4
Delhi 4
Frankfurt am Main 4
Ha Long 4
Houston 4
Istanbul 4
Kuala Lumpur 4
Lấp Vò 4
Mumbai 4
Pasadena 4
San Francisco 4
Seattle 4
São José dos Campos 4
Astana 3
Cairo 3
Calgary 3
Camaçari 3
Casablanca 3
Des Moines 3
Doha 3
Dubai 3
Genoa 3
Guarulhos 3
Hangzhou 3
Joinville 3
Kingston 3
Limburg an der Lahn 3
Manchester 3
Nairobi 3
New Delhi 3
Quận Bình Thạnh 3
Riyadh 3
Roden 3
Roubaix 3
Santiago 3
Tashkent 3
Turin 3
Totale 2.448
Salva come PNG Salva come JPEG
Nome #
Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life 419
A new prognostic and predictive tool for shared decision making in stage III colon cancer 101
Barriers and Facilitators in Diagnostic Pathways That Align Universal Tumor Screening and Mainstream Genetic Testing for Lynch Syndrome in Colorectal Cancer: Protocol for a Scoping Review With a Narrative Synthesis 86
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy 68
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 66
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 64
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials 64
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets 62
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 62
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer 61
Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study 61
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal Cancer 59
Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center 58
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3 58
Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancers 58
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting 57
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors 57
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 56
Lynch Syndrome: From Multidisciplinary Management to Precision Prevention 56
BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer 56
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma 55
The impact of ARID1A mutation on molecular characteristics in colorectal cancer 55
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAFV600E-mutated metastatic colorectal cancer treated with targeted therapy 55
Colorectal cancer: epigenetic alterations and their clinical implications 54
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal Cancer 50
A polymorphism within the Vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/ bevacizumab or FOLFIRI/Cetuximab 50
First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy? 46
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective 46
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis 46
New perspectives for colorectal cancer 46
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) 45
Research training, barriers, and career development needs of early-career investigators in oncology: an EORTC survey-based study 45
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic Phenotype 45
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial 45
Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 45
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer 44
Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study 44
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset 43
Redefining Colorectal Cancer by Tumor Biology 42
Molecular profile of BRCA-mutated biliary tract cancers 42
Cisplatin-related Atrial Fibrillation during PEB Chemotherapy for Testicular Seminoma: A Case Report 42
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 42
Tackling hurdles in front of young clinical investigators in oncology – Results from an international survey 41
Management of Advanced Small Bowel Cancer 41
What We Know About Stage II and III Colon Cancer: It's Still Not Enough 40
B cell and B cell-related pathways for novel cancer treatments 40
Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand? 40
Young Patients with Colorectal Cancer: Risk, Screening, and Treatment 40
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers 39
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy 39
The role of tumor angiogenesis as a therapeutic target in colorectal cancer 38
Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma 38
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM) 38
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study 38
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies 38
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer 38
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions 37
Outlooks on Epstein-Barr virus associated gastric cancer 37
From walls to wonder: Talking about spaces tailored for adolescents and young adults with cancer 36
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care? 35
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer 35
Microsatellite-Instability-High Advanced Colorectal Cancer 35
The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer 35
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience 34
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets 33
Safety and Tolerability of c-MET Inhibitors in Cancer 33
Metastatic sarcoma: tailored strategies for a heterogeneous disease 33
The urgent need to improve the tools to assess clinical benefit and value of cancer treatment 32
Molecular Variances Between Right- and Left-sided Colon Cancers 31
Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives 31
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients 31
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers 31
Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence? 31
Maintenance Olaparib for Metastatic Pancreatic Cancer 31
Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens 30
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives 30
The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives 30
Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study 29
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors 29
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients 29
Routinely Updating Patients With Cancer About Variant of Uncertain Significance Reclassifications: A Premature Responsibility for Community Oncologists 27
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3 27
Editorial: New therapeutic approaches in microsatellite stable colorectal cancer patients 27
Reliability of patient-reported toxicities during adjuvant chemotherapy 26
Practice-changing updates in the adjuvant and metastatic setting 26
Fertility Preservation Practices and Gastrointestinal (GI) Oncologist in Europe: A Pan-European study 25
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system 24
The Definition of Cure in Colon Cancer: A Pooled Analysis of 15 Randomized Clinical Trials 21
Universal tumor screening and mainstream genetic testing for Lynch syndrome in colorectal cancer: a scoping review of barriers and facilitators 18
Absence of co-occurrence between HER2 amplification and dMMR/MSI in a large multicentric colorectal cancer cohort 2
Totale 4.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 4 4 4
2024/2025793 1 2 1 4 1 123 79 109 74 182 75 142
2025/20263.400 362 228 546 389 91 158 585 208 283 233 202 115
Totale 4.205